Transgender Men, Non-binary Persons and Testosterone Treatment BODY IDENTITY CLINIC
ConditionTransgenderism
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorMarianne Andersen
About this trial
The aim of this study is to investigate transgender men and non-binary persons before and during testosterone treatment. The study will focus on:
* Cardiovascular status * Muscle strenght and power * Aggression and quality of life * Cardiac and respiratory function
Eligibility criteria
This trial accepts healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
Persons assigned female at birth (+18 years) that either use or want to use testosterone with the purpose of undergoing gender transformation. -
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
200 Participants
are grouped into 1 trial groupGroup A: transgender men
Trial outcomes
Primary outcomes
1
Effect of testosterone on devellopment of plaques in the heart
Estimated directly by CCTA, at start, (1 year for early included participants) 5 and 10 years
Time frame
10 yearsSecondary outcomes
1
Calcium score
CCTA
Time frame
10 years2
Change in muscle strength and power
Estimated by low row and accelometer at start, 1, 3, 5, 10 years
Time frame
10 years3
Effect of transgender treatment on quality of life
Estimated by quality of life questionnaire (SF36) at start, 1, 3, 5 and 10 years
Time frame
10 years4
Effect of transgender treatment on aggression
Estimated by aggression questionnaire at start, 1, 3, 5 and 10 years
Time frame
10 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Marianne Andersen
Lead sponsor
Odense University Hospital
Sponsor institution
Source ClinicalTrials.gov